𝕏xSE first seen 2 h ago, last 2 h ago, peak #32
Viking Therapeutics Shares Hover Near $30 Amid Obesity Drug Competition
Viking Therapeutics stock is trading close to the $30 mark as investors weigh the company's prospects in the increasingly crowded obesity drug market. The biotech, developing GLP-1-based treatments, is being watched closely against larger rivals such as Eli Lilly and Novo Nordisk, and market watchers are debating whether its obesity pill candidates can compete.
Why now: Investors are tracking the stock as competition intensifies in the fast-growing obesity drug market.
Viking TherapeuticsEli LillyNovo Nordisk
Rank over time, top of the chart is #1. 4 snapshots from 2 h ago to 2 h ago.
API: https://socialmediatrends-api.osmike.com/v1/trends/760421